The show, one of China's top medical technology exhibitions, starts today.  Newly Expanded Manufacturing of NEU™ Custom Capabilities and NEUSoft™ Thermoplastics Polyurethanes for catheter applications: now produced in Suzhou, China, offering customized services and rapid response times to customers from Asia Pacific, a series of ultra-soft TPUs for short-term in-vivo applications that are available in custom colors with excellent ultraviolet (UV) stability and barrier properties, offer good elasticity, resistance to abrasions and tears, barrier properties, and melt strength for use in a host of catheter applications, including cardiovascular, intravenous, and other specialty segments . Medical-grade pharmaceutical packaging solutions: oxygen scavenging additives, amber and white colorants, and white HDPE for MVTR (Moisture Vapor Transmission rate) reduction to protect drugs or nutraceuticals against UV light, moisture, and oxygen that cause product degradation.

CLARET RED AM-UV PC-ABS 2 GRAPE JUICE AM-UV PC-ABS 2 PASSION BLUE AM-UV PC-ABS 2

DJ GLOBAL GREY 2 STX GT6000-0002 LAVA BLACK 6.6 Blend-2 X ST 12535-001-2

GLOW TEAL BLUE TP 2 UV FL YELLOW 2 FDA BLACK 2

UV MET STORM GRAY NYL V2 SILCOPAS BLACK 108054 BLACK ZEONOR COP

050OR2069 ORANGE UV TPU BLACK FOREST (GN) UV HELTON BLACK PP

UV Green 2 DB4539A BLACK TEX (PVCBLK112) UV BLACK PE

Microsoft PowerPoint - AVNT Q4 2021 Earnings Presentation (v17) - W PEERS x ESI AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 1 R E S U L T S A N D 2 0 2 2 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A RY 8 , 2 0 2 2 DISCLAIMER Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Purchase price multiple rapidly declining on strength of business and synergy capture 10 $133 $205 2019PF 2021 10 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.1x 2019PF 2021 2021 w/ Full Synergies 11.9% 16.2% 2019PF 2021 EBITDA Margins CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION (1) Financial information is pro forma to include a full year of Clariant Color business ($ millions) Initial Synergy Estimate 2021 Synergy Realization Total Synergies Expected Administrative $ 18 $ 29 $ 40 Sourcing 24 20 24 Operational 18 5 21 Total Synergies $ 60 $ 54 $ 85 CLARIANT COLOR INTEGRATION & COST SYNERGIES UPDATE 11 • Integration going extremely well: synergy target increased to $85 million at December 9th Investor Day • Relentless focus on guiding principles of safety first, employee collaboration and exceeding customer expectations • Future revenue synergies are not part of these estimates and represent additional growth over the long term SUSTAINABILITY FOR A BETTER TOMORROW • Revenue from sustainable solutions grew 16% in 2021 and expected to grow 8-12% in 2022 as our innovation efforts and collaboration with customers accelerates • Investments centered around innovation and global sustainability megatrends o Enabling a circular economy – Technologies that allow for increased use of post-consumer recycled (PCR) material and improve recyclability of plastics o Light-weighting – Composites and CAI applications to reduce weight and material requirements, which minimize energy and carbon emissions o Eco-Conscious – Health and human safety applications as well as Avient’s alternative materials to replace lead, PVC, halogens, BPA and other less eco-friendly options *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business 2016 2017 2018 2019 2020PF** 2021 $405M $455M $550M $790M Revenue From Sustainable Solutions* 2016-2021 $915M $340M PEOPLE C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $16 million raised since 2010 Diversity & Inclusion 13 Q4 2020 $997 $80 Sustainable Solutions 23 12% 8 Healthcare 53 43% 9 Composites 7 22% 2 Growth in Asia / LATAM 14 10% 3 Other 118 23% 2 Sub-total $1,212 22% $104 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 9 Incentives, FX, Other Employee Costs (10) (13) Q4 2021 $1,202 21% $85 Q4 2021 SALES AND OPERATING INCOME 14 Sales Growth Rate Operating Income$ millions Q4 EBITDA BRIDGE 15 Price increases more than offsets raw material and supply chain impacts Q4 2020 $ 118 Demand - $ millions CAI: Price / Mix 62 Inflation (45) SEM: Price / Mix 25 Inflation (20) Distribution: Price / Mix 114 Inflation (109) Net Price Benefit 27 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 9 Incentives, FX, Other Employee Costs (13) Q4 2021 $ 126 Transportation (5)$ Outdoor High Performance (3) Other 8 Total Demand - Q4 2021 SEGMENT PERFORMANCE 16 $526 $581 SEM Distribution $58 $61 + 11% + 6% $305 $425 $18 $22 + 39% + 22% $191 $228 $30 $29 + 19% - 3% 2022 O U TLO O K REVENUE GROWTH DRIVERS Growth Drivers Long-Term Growth Rate 2022E Growth Rate Sustainable Solutions 8–12% 12% Healthcare 8–10% 10% Composites 10% 3% Asia / LATAM 5% 6% Other (GDP growth) 2–3% 2–3% Avient 6.5% 6% 18 Excluding Outdoor High Performance 13% (7.5% excl. FX) 2022 GROWTH PROJECTIONS 19 $3.05 $3.50 2021 2022E Full Year – Adjusted EPS + 15% (+ 17% excluding FX) $0.89 $0.95 2021 2022E Q1 – Adjusted EPS + 7% (+ 10% excluding FX) ($ millions) Q1 Full Year Q1 Full Year 2021 - Actual 1,162$ 4,819$ 123$ 429$ Sustainable Solutions 27 110 12 44 Healthcare 15 66 4 13 Composites (excl.Outdoor High Performance) 11 29 5 13 Outdoor High Performance Applications (7) (20) (4) (10) Growth in Asia / LATAM 10 51 3 11 Other 57 115 9 12 Sub-total 1,275$ 5,170$ 152$ 512$ Wage Inflation and Overtime (12) (18) Other Supply Chain Costs (4) (7) FX Impact (25) (70) (4) (8) Synergies 4 15 Travel, Other Employee Costs (1) (4) 2022 - Estimated 1,250$ 5,100$ 135$ 490$ Adjusted 2022 SALES AND OI – Q1 AND FULL YEAR 20 ($ millions) 2021 2022E Cash Flow from Operating Activities 234$ 385$ Less: Run-Rate CapEx (86) (90) CapEx for Clariant Integration (15) (20) CapEx for IT System Upgrade - (25) Total CapEx (101) (135) Free Cash Flow 133$ 250$ Adjusted EBITDA 581$ 635$ Net Debt / Adjusted EBITDA 2.2x 1.8x 21 CASH FLOW / LEVERAGE 22 • Record results – highest level of sales ($4.8B) and earnings ($3.05 adjusted EPS) in company history • Successful Clariant Color integration – net debt to adjusted EBITDA reduced to 2.2x, one-year ahead of schedule • Recognized as one of America’s Most Responsible Companies by Newsweek • Earned 3rd consecutive Great Place to Work certification 2021 HIGHLIGHTS 23 • 15% adjusted EPS growth to $3.50, led by growth in sustainable solutions and increased synergy realization • Continued strong synergy capture from the Clariant Color integration: $75M anticipated run-rate synergies by the end of 2022 • Adjusted EBITDA of $635M represents 9% growth above 2021 – 11% excluding the impact of foreign currencies • Deleveraged to 1.8x net debt to adjusted EBITDA by the end of 2022 2022 SUMMARY PEER COMPARISONS 25 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.

UV AMENDOLA 2 ASA N1.2-BLACK/3950X BLACK TPU

WHITE W/ UV V.3 UV CEL. X NM-8150-003-12-2 Black